Under a hypoxic environment, the intensity of HIF-1 fluorescence dropped considerably when treated with Fe-TBP (at an equivalent ligand dosage of 10 μM in vitro and 0.2 μmol in vivo), demonstrating hypoxia relief at the tumor level. The gene discussed is SETD2; the disease is neoplasm.